HOME >> MEDICINE >> NEWS
Study drug holds promise as alternative to castration for early prostate cancers

For those unwilling to undergo chemical castration however, results of an international study led by a Medical College of Wisconsin researcher show promise for an oral drug as an alternative. The study appears in the August issue of the Journal of Cancer Research and Clinical Oncology.

"In patients with locally-advanced disease, a daily 150 mg dose of bicalutamide, (Casodex TM) following initial radiotherapy, has shown significant clinical benefits in terms of overall survival and progression-free survival, compared with radiotherapy alone," says study author William A See, M.D., chairman and professor of urology at the Medical College in Milwaukee, and chief of urologic surgery at Froedtert Hospital.

The double-blind, randomized study followed 1,370 early prostate cancer patients in the U.S., Sweden and Europe who received radiotherapy with curative intent. After a median follow-up of 7.2 years, the researchers found that those receiving a daily, 150 mg oral dose of Casodex TM reduced their risk of disease progression by 44 percent, and their overall risk of death by 35 percent, compared to those receiving a placebo. "Although many of the adverse effects of castration therapy are manageable, they can have a detrimental effect on quality of life," says Dr. See "Here we have evaluated the efficacy and tolerability of a non-castration-based therapy, and found the survival rates to be similar."


'"/>

Contact: Eileen LaSusa
lasusa@mcw.edu
414-456-4746
Medical College of Wisconsin
22-Aug-2006


Page: 1

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... 2019 , ... Residents in long-term-care nursing facilities were prescribed fewer medications when ... to a study of U.S. men and women led by the staff at ... Institute (BRI) . The quality assurance study examined the high number of prescriptions ordered ...
(Date:4/18/2019)... ... April 18, 2019 , ... BNCT ... to deliver targeted radiation to cancer cells while sparing surrounding healthy tissue. NTI’s ... platforms. Engineered from the ground up for high reliability and ease of maintenance, ...
(Date:4/18/2019)... ... 18, 2019 , ... She went from learning disabled to honor roll – ... Cheryl Reilly. Those “goofy tests,” performed by Deborah Zelinsky, O.D. , founder of ... had such narrow range of visual awareness, she could only see what was directly ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... advice. However, recently, this reluctance appears to be changing. Whether because of demographic ... at least, probe their healthcare providers advice. , In the past, efforts to ...
(Date:4/17/2019)... ... , ... Fertility Centers of Illinois will recognize ... unite millions of Americans aiming to remove the stigmas and barriers associated with ... of Illinois is offering seven free physician-led webinars and free Fertility Awareness Checkups, ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Bioclinica®, a leading provider of ... development of medical therapies, announced today that it has assembled a team of ... nonalcoholic steatohepatitis (NASH), to help sponsors develop therapeutics using medical imaging and other ...
(Date:4/18/2019)... ... April 18, 2019 , ... Global Lyme Alliance ... research, education, and awareness, and Ranger Ready Repellents, a new EPA-registered brand ... of tick-bite prevention, including the proper use of repellents, to safeguard the public ...
(Date:4/17/2019)... ... , ... Salt Lake Community College has named Jay K. Francis ... at SLCC’s May 3 Commencement at the Maverik Center, 3200 S. Decker Lake Drive, ... Miller Family Philanthropy. Richards is president and CEO of SelectHealth. , Francis studied business ...
Breaking Medicine Technology:
Cached News: